https://news.augustaheadlines.com/story/419032/pepe-climbs-to-70-million-in-volume-in-24-hours-gears-up-for-exchange-listings-and-major-price-jump.html 2023-04-19T23:39:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/419030/the-most-popular-wedding-officiant-in-ny-get-lastminute-sameday-service-with-maksim-kondratenko.html 2023-04-19T23:30:04+00:00 daily 1.0 https://news.augustaheadlines.com/story/419088/propulsion-of-osteoarthritis-pipeline-as-novel-and-extensive-130-therapies-likely-to-enter-in-the-treatment-domain-major-companies-gsk-gilead-sciences-novartis-astrazeneca-and-others.html 2023-04-19T23:22:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/419028/skills-for-success-2023-empower-future-with-targeted-skill-development.html 2023-04-19T23:18:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/419086/delveinsight-highlights-major-metastatic-melanoma-pipeline-therapies-and-75-leading-players-wheeling-the-hypertension-pipeline-landscape.html 2023-04-19T23:16:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/419085/small-cell-lung-cancer-clinical-trials-pipeline-analysis-100-companies-are-working-to-improve-the-treatment-space-major-companies-merck-co-glaxosmithkline-astrazeneca-and-others.html 2023-04-19T23:14:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/419026/a-team-real-estate-solutions-expands-into-all-illinois-markets-enabling-homeowners-to-sell-their-homes-fast-and-efficiently.html 2023-04-19T23:09:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/419083/renal-cell-carcinoma-pipeline-as-30-influential-pharma-companies-to-set-foot-in-the-domain-major-companies-astrazeneca-novartis-pfizer-and-others.html 2023-04-19T23:08:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/419024/effortlessly-achieve-youthful-radiant-complexion-with-ab-skin-deluxes-antiaging-skincare-line.html 2023-04-19T23:06:38+00:00 daily 1.0 https://news.augustaheadlines.com/story/419081/rheumatoid-arthritis-pipeline-booms-as-95-companies-likely-to-enter-in-the-treatment-domain-major-companies-silo-pharma-remegen-pfizer-novartis-and-others.html 2023-04-19T23:06:02+00:00 daily 1.0